4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0000947871-24-000720
Director sold 868,682 shares at an average $13.24 ($11,497,963)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2024-08-21 | Sale | −394,400 | $13.52 | $5,332,288 | 557,977 | I |
| ORBIMED ADVISORS LLC Director | 2024-08-21 | Sale | −13,300 | $14.61 | $194,313 | 544,677 | I |
| ORBIMED ADVISORS LLC Director | 2024-08-22 | Sale | −391,482 | $12.94 | $5,065,777 | 153,195 | I |
| ORBIMED ADVISORS LLC Director | 2024-08-23 | Sale | −69,500 | $13.03 | $905,585 | 83,695 | I |
| Open-market sales · 868,682 sh · avg $13.24 · $11,497,963 | |||||||
Loading xslF345X05/ownership.xml…